{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01808",
      "entity_text" : "type 2 receptors",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01814",
      "entity_text" : "type 1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "Cellular_component" : [ "go:GO:0005634" ]
    }
  },
  "verbose_text" : "In response to TGF-beta, type 1 (ALKs 1-7 in humans) and type 2 receptors (ActR-IIA, ActR-IIB, BMPR-II, AMHR-II and TbR-II, in humans) form complexes and the constitutively active type 2 serine/threonine kinase phosphorylates the type 1 receptor.",
  "reading_complete" : "2020-08-03T12:21:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T12:16:36Z",
  "trigger" : "form complexes",
  "evidence" : [ "type 1 (ALKs 1-7 in humans) and type 2 receptors (ActR-IIA, ActR-IIB, BMPR-II, AMHR-II and TbR-II, in humans) form complexes" ],
  "pmc_id" : "3227652",
  "score" : 0
}